Michael Krachon
CEO, Theragenics
Michael L. Krachon brings more than 30 years’ experience of progressive growth in sales, marketing and management in the medical industry. Mr. Krachon is President of Theragenics Interventional, following previous positions at IsoRay Medical and CR Bard. Over his career Mr. Krachon has been involved in developing and leading effective sales teams, driving significant revenue growth, strategic planning, developing international business segments and creating and delivering the international product launches.
Panel Discussion: The Future of Medical Device Marketing
Panelists
Jennifer Burnham, Abbott
Angela Esposito, Chronic Consultancy LLC
Bobak Salehi, BIOTRONIK
Moderator
Michael Krachon, CEO, Theragenics
Session Overview
This panel brings together industry leaders to explore the trends, technologies, and strategies shaping the future of medical device marketing. From AI and omnichannel engagement to evolving customer expectations and commercialization models, discover what's next for MedTech marketers.
Implementing New Technology and Maximizing Impact – An Executive Perspective
Michael Krachon
Vice President of Marketing, Theragenics
Session Overview
Successfully adopting new technologies requires more than selecting the right tools. This session explores practical strategies for evaluating emerging technologies, including AI, driving organizational adoption, and measuring their impact to deliver meaningful business value.
Key Takeaways
- Best practices for assessing and evaluating new technologies, including AI, within an established organization.
- Strategies for maximizing technology adoption while improving internal processes and operational efficiency.
- How to measure technology impact, demonstrate business value, and exceed organizational expectations.